Valuation: Tristel plc

Market Cap 197M 265M 230M 214M 370M 25.26B 376M 2.52B 986M 12.66B 996M 975M 41.88B P/E 2026 *
25x
P/E 2027 * 21.7x
Enterprise Value 187M 252M 218M 204M 352M 24.03B 357M 2.39B 938M 12.04B 947M 927M 39.84B EV / Sales 2026 *
3.66x
EV / Sales 2027 * 3.3x
Free-Float
93.07%
Yield 2026 *
3.62%
Yield 2027 * 3.83%
1 day-4.33%
1 week-4.33%
Current month-4.33%
1 month+3.80%
3 months+3.80%
6 months-1.88%
Current year+11.67%
1 week 5.74
Extreme 5.74
5.74
1 month 5.28
Extreme 5.28
6
Current year 5
Extreme 5
6
1 year 5
Extreme 5
6
3 years 5
Extreme 5
6
5 years 5
Extreme 5
6
10 years 5
Extreme 5
6
Manager TitleAgeSince
Chief Executive Officer 64 2026-07-31
Director of Finance/CFO - 2024-12-31
Chief Executive Officer - 2026-06-29
Director TitleAgeSince
Director/Board Member 54 2017-10-18
Chairman 65 2019-12-16
Director/Board Member 68 2020-04-26
Change 5-day change 1-year change 3-year change Capi.($)
-4.33%-4.33% - - 266M
+2.68%+1.89%-27.85%-45.97% 15.23B
+1.45%+0.18%+31.55%+132.05% 4.85B
-2.30%-6.24%+286.76%+202.66% 3.33B
+0.17%-3.52%-27.97%-30.33% 2.55B
+0.58%+2.38%-51.14%-62.81% 1.98B
-8.08%-11.94%-30.42%-28.84% 1.88B
-0.79%-6.02%+1.63%-28.98% 1.23B
+9.52%+12.67%-1.51%-14.29% 1.06B
+11.07%+8.59%-0.93%+20.59% 1.02B
Average +1.00%+0.24%+20.01%+16.01% 3.68B
Weighted average by Cap. +1.37%+0.42%+13.73%+9.98%

Financials

2026 *2027 *
Net sales 51.15M 68.99M 59.68M 55.73M 96.2M 6.57B 97.63M 654M 256M 3.29B 259M 253M 10.89B 56.28M 75.91M 65.66M 61.33M 106M 7.23B 107M 720M 282M 3.62B 285M 279M 11.98B
Net income 7.93M 10.7M 9.26M 8.64M 14.92M 1.02B 15.14M 101M 39.77M 511M 40.15M 39.3M 1.69B 9.19M 12.4M 10.73M 10.02M 17.29M 1.18B 17.55M 118M 46.08M 592M 46.53M 45.54M 1.96B
Net Debt -9.59M -12.93M -11.19M -10.45M -18.03M -1.23B -18.3M -123M -48.05M -617M -48.51M -47.49M -2.04B -11.29M -15.23M -13.18M -12.31M -21.24M -1.45B -21.56M -144M -56.61M -727M -57.15M -55.94M -2.4B
Logo Tristel plc
Tristel plc is a United Kingdom-based infection prevention company. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. It addresses pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
Employees
270
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4.100GBP
Average target price
4.752GBP
Spread / Average Target
+15.90%

Annual profits - Rate of surprise